(Q58448791)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844116%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

1,5-Anhydro-D-fructose increases glucose tolerance by increasing glucagon-like peptide-1 and insulin in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844116%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

0 references

1 reference

S Yu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844116%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844116%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844116%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

397

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844116%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844116%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

219-225

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844116%20AND%20SRC:MED&resulttype=core&format=json

Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900261-2

Analysis of 1,5-anhydro-D-fructose, microthecin, and 4-deoxy-glycero-hexo-2,3-diulose in algae using gas chromatography-mass spectrometry in selected ion monitoring mode

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900261-2

Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900261-2

GLP-1 tablet in type 2 diabetes in fasting and postprandial conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900261-2

Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900261-2

On the treatment of diabetes mellitus with glucagon-like peptide-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900261-2

Hepatic production of 1,5-anhydrofructose and 1,5-anhydroglucitol in rat by the third glycogenolytic pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900261-2

Differential effects of prolonged hyperglycemia on in vivo and in vitro insulin secretion in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900261-2

Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900261-2

Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900261-2

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900261-2

PTG, a protein phosphatase 1-binding protein with a role in glycogen metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900261-2

Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900261-2

Purification and some properties of a hepatic NADPH-dependent reductase that specifically acts on 1,5-anhydro-D-fructose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900261-2

Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900261-2

1,5-Anhydroglucitol promotes glycogenolysis in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900261-2

Stimulation of truncated glucagon-like peptide-1 release from the isolated perfused canine ileum by glucose absorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900261-2

alpha-1,4-glucan lyases producing 1,5-anhydro-D-fructose from starch and glycogen have sequence similarity to alpha-glucosidases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900261-2

10.1016/S0014-2999(00)00261-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10844116%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference